Co-Authors
This is a "connection" page, showing publications co-authored by Jerzy Jaroszewicz and Krzysztof Tomasiewicz.
Connection Strength
0.653
-
Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study. Pol Arch Intern Med. 2021 01 29; 131(1):103-110.
Score: 0.230
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021. Pol Arch Intern Med. 2021 05 25; 131(5):487-496.
Score: 0.059
-
Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6. J Clin Med. 2021 Apr 09; 10(8).
Score: 0.059
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020. Pol Arch Intern Med. 2020 10 29; 130(10):915-918.
Score: 0.057
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 1 as of June 8, 2020. Pol Arch Intern Med. 2020 06 25; 130(6):557-558.
Score: 0.055
-
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020. Pol Arch Intern Med. 2020 04 30; 130(4):352-357.
Score: 0.055
-
Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C - a real-world study. Clin Exp Hepatol. 2019 Sep; 5(3):215-223.
Score: 0.053
-
Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals? J Interferon Cytokine Res. 2018 02; 38(2):93-100.
Score: 0.047
-
Distribution of HBV genotypes in Poland. Clin Exp Hepatol. 2015 May; 1(1):1-4.
Score: 0.039